Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Stark Novus Financial Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0.19
2.34
Cost of revenue
30
91.6
Gross profit
-29.8
-89.2
Research and development
71
284
108
33.3
Selling, general and administrative
54.4
12.9
6.77
Selling and marketing
31.3
105
138
General and administrative
0.62
Operating expenses
102
400
357
260
10.9
3.76
Operating income
-0.62
-102
-400
-387
-349
-10.9
-3.76
Interest expense
0.7
Interest income
6.63
2.75
1.79
Other non-operating income
-20.9
-10.1
0.79
0.12
-0.25
0.02
Pre-tax income
3.93
-124
-410
-282
-343
-8.14
-0.62
Income tax
0
0
0
0
0
Net income
3.02
-124
-410
-282
-343
-8.14
-0.62
EBITDA
-0.62
-102
-400
-294
EPS, basic
-19.27
-34.17
-20.32
-21.67
-0.67
-0.22
EPS, diluted
-19.27
-34.17
-20.32
-21.67
-0.67
-0.22
Shares, basic (weighted)
6.43
12
13.9
0.02
16.1
16.1
Shares, diluted (weighted)
6.43
12
13.9
0.02
16.1
16.1
Balance sheet
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
2.16
630
244
121
87.1
23.1
34.4
Short-term investments
100
6.37
4.72
Receivables
0.02
Inventory
13.7
Other current assets
0.1
24.7
47.1
1.04
2.22
0.14
0.18
Total current assets
2.16
654
291
256
92.1
53.2
44.8
Property, plant and equipment
20.3
102
383
194
Other non-current assets
13.9
2.66
0.03
2.22
Total assets
33.5
767
689
452
92.2
53.2
47
Accounts payable
1.8
32.5
12.1
12.8
0.93
0.14
0.46
Total current liabilities
25
34.1
148
68.8
15.4
1.06
0.99
Long-term debt
1.02
Total liabilities
25
136
149
70.3
45.9
10.9
6
Paid-in capital
18.9
765
1,084
1,179
1,184
1,185
1,182
Retained earnings
-10.4
-134
-545
-827
-1,170
-1,178
-1,179
Other comprehensive income
0.67
-0.41
Shareholders' equity
8.56
631
540
352
13.5
6.78
2.6
Total equity
8.56
631
540
352
13.5
6.78
2.6
Total liabilities and equity
33.5
767
689
452
92.2
53.2
47
Shares outstanding
68.3
11.2
13
15.9
16
Cash flow statement
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
3.02
-124
-410
-282
-343
-8.14
-0.62
Depreciation and amortization
0
0
0
54.4
Stock-based compensation
2.76
18.7
18.8
7.4
3.51
0.43
Change in receivables
-0.02
0.02
-0.2
0.2
Change in inventory
-54.6
-10.5
Change in payables
0.29
25.8
-17
2.53
-11.9
-0.8
0.33
Cash from operations
-1.39
-99.6
-388
-214
-137
-35.1
-7.23
Capital expenditures
-52.6
-285
-54.6
-10.2
Purchases of investments
-1
-100
-32.1
-38.8
-29.2
Cash from investing
-279
-50.2
-286
-115
103
-28.8
18.6
Stock issued
0
6.44
6.37
2.11
Cash from financing
281
777
288
206
-0.11
Net change in cash
1.05
628
-386
-123
-34.3
-64
11.3
Free cash flow
-152
-673
-268
-147
Income taxes paid
0.97
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.80 on September 2, 2026.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-310.8%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-3.0%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
-61.7%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-80.5%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-66.7%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-11.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-53.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-42.8%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.2%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
5.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
20.2%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
40.2x
Current assets / current liabilities.
Quick ratio
36.2x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
36.2x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share
-$0.42
Cash from operations / diluted weighted shares.
Book value per share
$0.03
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
69.2x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
69.2x
Market cap / tangible book value, when positive.
Earnings yield
-4.5%
Net income / market cap (the inverse of P/E).
Was Stark Novus Financial Inc. profitable in fiscal 2025?
No. It reported a net loss of $619.0K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.